Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann W Morgan

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|May 10, 2022
Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort StudyMichael Drozd, Mar Pujades-Rodriguez, Ann W Morgan, et al.
Arthritis and Rheumatism|November 10, 2010
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven lociDarren Plant, John Bowes, Catherine Potter, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Rheumatology (Oxford, England)|October 11, 2019
Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritisNisha Nair, Darren Plant, Suzanne M Verstappen, et al.
Arthritis Research & Therapy|December 16, 2015
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesSamantha Louise Smith, Stephen Eyre, Annie Yarwood, et al.
Arthritis and Rheumatism|April 29, 2008
The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohortAnn W Morgan, Lubna Haroon-Rashid, Stephen G Martin, et al.
Human Molecular Genetics|August 21, 2008
Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritisJames R Maxwell, Catherine Potter, Kimme L Hyrich, et al.
Rheumatology (Oxford, England)|November 21, 2009
Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritisBatool Hassan, James R Maxwell, Kimme L Hyrich, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|May 10, 2022
Systemic Inflammation Is Associated With Future Risk of Fatal Infection: An Observational Cohort StudyMichael Drozd, Mar Pujades-Rodriguez, Ann W Morgan, et al.
Arthritis and Rheumatism|November 10, 2010
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven lociDarren Plant, John Bowes, Catherine Potter, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Rheumatology (Oxford, England)|October 11, 2019
Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritisNisha Nair, Darren Plant, Suzanne M Verstappen, et al.
Arthritis Research & Therapy|December 16, 2015
Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samplesSamantha Louise Smith, Stephen Eyre, Annie Yarwood, et al.
Arthritis and Rheumatism|April 29, 2008
The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohortAnn W Morgan, Lubna Haroon-Rashid, Stephen G Martin, et al.
Human Molecular Genetics|August 21, 2008
Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritisJames R Maxwell, Catherine Potter, Kimme L Hyrich, et al.
Rheumatology (Oxford, England)|November 21, 2009
Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritisBatool Hassan, James R Maxwell, Kimme L Hyrich, et al.
Pageof 14